Unlike the great existing knowledge on GF in preclinical models of cerebral ischemia, there is a gap in studies in clinical practice which may be one of the reasons why clinical trials with GF such as granulocyte colony-stimulating factor (G-CSF) have failed [13, 14]. The gene discussed is CSF3; the disease is Cerebral ischemia.